Healthcare & Pharmaceutical

The rise in new variants of the Coronavirus and poor access to vaccines in developing countries will derail the recovery of economies across the world, warn the finance ministers o

Flagship Pioneering, the bioplatform company, and the venture capital investor in Moderna, today announced that it had raised additional funding of $2.23 billion, which brings its

The Food and Drug Administration of the US approved on Monday Biogen Inc’s Aducanumab to treat Alzheimer’s disease amidst the controversy of its efficacy. Biogen has pr

Johnson & Johnson is appealing for a review by the Supreme Court of an award of $2 billion to a group of women who claimed they developed ovarian cancer from using the company&

Bristol-Myers Squibb, the Big Pharma company, has entered into a drug discovery collaboration worth $1.2 billion, with artificial intelligence (AI) pharmatech company, Exscientia.

AstraZeneca’s first-quarter earnings doubled, with its Covid-19 vaccine generating $275 million in revenue. The pharma company’s revenue for the quarter rose 15 percent

Denmark has decided to temporarily suspend the use of the coronavirus vaccine developed by AstraZeneca and the University of Oxford due to reports of adverse blood clot reactions a

The COVID-19 vaccine rollout is likely to determine how quickly the real estate market recovers after the Pandemic. According to international real estate company Savills, homeowne

Moderna Inc., the Boston-based biotech startup, reported its fourth quarter and 2020 fiscal year results, where it announced that it hoped to bring in $18.4 billion in 2021 from it